- Home
- VIGL vs GRWG Comparison
VIGL vs GRWG Comparison
Compare VIGL & GRWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIGL
- GRWG
- Stock Information
- Founded
- VIGL 2020
- GRWG 2008
- Country
- VIGL United States
- GRWG United States
- Employees
- VIGL N/A
- GRWG N/A
- Industry
- VIGL Biotechnology: Pharmaceutical Preparations
- GRWG RETAIL: Building Materials
- Sector
- VIGL Health Care
- GRWG Consumer Discretionary
- Exchange
- VIGL Nasdaq
- GRWG Nasdaq
- Market Cap
- VIGL 134.9M
- GRWG 51.8M
- IPO Year
- VIGL 2022
- GRWG N/A
- Fundamental
- Price
- VIGL $8.05
- GRWG $1.05
- Analyst Decision
- VIGL Buy
- GRWG Buy
- Analyst Count
- VIGL 7
- GRWG 4
- Target Price
- VIGL $8.00
- GRWG $2.38
- AVG Volume (30 Days)
- VIGL 1.1M
- GRWG 920.8K
- Earning Date
- VIGL 08-12-2025
- GRWG 08-07-2025
- Dividend Yield
- VIGL N/A
- GRWG N/A
- EPS Growth
- VIGL N/A
- GRWG N/A
- EPS
- VIGL N/A
- GRWG N/A
- Revenue
- VIGL N/A
- GRWG $176,681,000.00
- Revenue This Year
- VIGL N/A
- GRWG N/A
- Revenue Next Year
- VIGL N/A
- GRWG N/A
- P/E Ratio
- VIGL N/A
- GRWG N/A
- Revenue Growth
- VIGL N/A
- GRWG N/A
- 52 Week Low
- VIGL $1.31
- GRWG $0.82
- 52 Week High
- VIGL $8.06
- GRWG $2.70
- Technical
- Relative Strength Index (RSI)
- VIGL 88.18
- GRWG 50.33
- Support Level
- VIGL $7.86
- GRWG $0.97
- Resistance Level
- VIGL $8.05
- GRWG $1.04
- Average True Range (ATR)
- VIGL 0.02
- GRWG 0.07
- MACD
- VIGL -0.15
- GRWG 0.00
- Stochastic Oscillator
- VIGL 73.15
- GRWG 61.29
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.